MENU
ZYME
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Zymeworks (ZYME) Ownership - Who owns Zymeworks?

Profile

Industry
Pharmaceuticals Major
Address
108 Patriot Drive
Phone
+1 302 274-8744
Employees
277
Web
https://www.zymeworks.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
920.89M
P/E Ratio
N/A
Total Cash
297.2M
Projected Growth
N/A
Total Debt
20.25M
Revenue
62.2M
Risk (Beta)
1.63
Dividend Yield
N/A
Total Cash/Share
4.31
Total Debt/Equity
N/A
Revenue/Share
0.83 USD as % of share price

Fundamentals

ZYME
Capitalization
921M
P/E Ratio
N/A
Risk (Beta)
1.63
Dividend Yield
N/A
Total Cash
297M
Total Cash/Share
4.31
Total Debt
20.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.83%
Revenue
62.2M
ROE
N/A
Book Value
367M
P/B Ratio
2.51
Cash Flow
N/A
Earnings
-1.49
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.02B
Current Ratio
4.10
Current Revenue Per Employee
55172.41
Dividends Per Share - Security
N/A
EBITDA
-110.13M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-21.79
Shares Held By Institutions
829M
Shares Outstanding - Current
68.9M
Total Liabilities
120M
Total Volume MTD
N/A
Value
N/A
Gain YTD
28.681
View a ticker or compare two or three
ZYME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company for cancer & autoimmune treatment

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
108 Patriot Drive
Phone
+1 302 274-8744
Employees
277
Web
https://www.zymeworks.com